The drug is superior to first line FDA approved drugs and passed GLP which derisks safety significantly. Great work team
Ann: NYR Completes Safety Studies Ahead of Phase I Clinical Trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.015(4.29%) |
Mkt cap ! $70.65M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 31.0¢ | $139.6K | 429.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 133773 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 30009 | 1 |
View Market Depth
| Last trade - 14.43pm 22/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |